The Spectrum of Acute Cerebrovascular Disease in Patients with COVID-19

Rachel Triay1, Prabandh Buchhanolla2, Alexas Gaudet1

  • 1LSU Health Shreveport School of Medicine, Louisiana State University Shreveport, Shreveport, LA 71103, USA.

Biomedicines
|February 25, 2022
PubMed

Insights

COVID-19 patients with acute cerebrovascular disease (CVD) experienced more severe strokes and longer hospital stays. This COVID-19 complication led to significantly worse clinical outcomes and higher mortality rates compared to non-COVID-19 CVD cases.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • The ongoing COVID-19 pandemic has been linked to various neurological complications.
  • Acute cerebrovascular disease (CVD) is an observed complication in patients with SARS-CoV-2 infection.
  • Understanding the specific impact of COVID-19 on CVD is crucial for patient management.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of acute cerebrovascular disease in hospitalized COVID-19 patients.
  • To compare the presentation and prognosis of CVD in COVID-19 patients versus non-COVID-19 patients.
  • To identify unique clinical phenotypes and adverse outcomes associated with COVID-19-related CVD.

Main Methods:

  • A retrospective, observational study was conducted on hospitalized adult patients.
  • Data from 32 patients with SARS-CoV-2 and acute CVD were reviewed.
  • Clinical data included epidemiology, features, labs, imaging, management, and outcomes, compared to a control group.

Main Results:

  • COVID-19 patients with CVD showed higher NIH stroke scale scores on discharge and longer hospital stays (13 days vs. 5 days).
  • Ischemic strokes predominated (81%), with seizures occurring in 16% of COVID-19 CVD patients.
  • Adverse outcomes were more frequent in COVID-19 CVD patients, including 31% mortality and 6% hospice discharge, versus 6% mortality in controls.

Conclusions:

  • Acute cerebrovascular disease associated with COVID-19 presents a distinct and more complicated clinical phenotype.
  • COVID-19-related CVD is associated with prolonged hospital admissions and significantly worse clinical outcomes.
  • The findings highlight the severe neurological impact of COVID-19 and underscore the need for vigilant monitoring and management of CVD in these patients.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
103
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
42
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
641
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44